chr10-58277191-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018464.5(CISD1):c.106G>A(p.Val36Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018464.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CISD1 | NM_018464.5 | c.106G>A | p.Val36Ile | missense_variant | 2/3 | ENST00000333926.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CISD1 | ENST00000333926.6 | c.106G>A | p.Val36Ile | missense_variant | 2/3 | 1 | NM_018464.5 | P1 | |
CISD1 | ENST00000464703.5 | n.297G>A | non_coding_transcript_exon_variant | 3/5 | 5 | ||||
CISD1 | ENST00000488388.2 | n.127G>A | non_coding_transcript_exon_variant | 2/4 | 5 | ||||
CISD1 | ENST00000489785.5 | n.174G>A | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000802 AC: 2AN: 249506Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134918
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460436Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726540
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2024 | The c.106G>A (p.V36I) alteration is located in exon 2 (coding exon 2) of the CISD1 gene. This alteration results from a G to A substitution at nucleotide position 106, causing the valine (V) at amino acid position 36 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at